Spending growth on retail prescriptions drugs in the US slowed to 1.3% in 2016 after recording much stronger growth rates of 8.9% and 12.4% in 2015 and 2014 respectively, according to actuaries at the Centers for Medicare and Medicaid Services. Retail drug spending reached $328.6bn last year.
The deceleration reflects fewer new drug approvals and lower hepatitis C and diabetes drug spending, CMS says in its latest...